Alerts will be sent to your verified email
Verify Email
ADVIKLA
|
MPS Pharmaa
|
Hemo Organic
|
Zyden Gentec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-55.68 % | -361.35 % | -24.76 % |
|
5yr average Equity Multiplier
|
4.57 | -1.56 | 2.0 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.14 | 0.21 |
|
5yr Avg Net Profit Margin
|
-87.46 % | -763.22 % | -137.59 % |
|
Price to Book
|
3.7 | 0.0 | n/a |
|
P/E
|
0.0 | 50.13 | n/a |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 100.48 Days | 785.76 Days |
|
Inventory Days
|
1258.79 Days | 406.93 Days | 134.34 Days |
|
Days Receivable
|
0.0 | 196.55 Days | 803.05 Days |
|
Days Payable
|
414.72 Days | 2776.86 Days | 421.99 Days |
|
5yr Average Interest Coverage Ratio
|
-777.17 | -250.54 | -2.08 |
|
5yr Avg ROCE
|
-52.41 % | 37.52 % | -6.92 % |
|
5yr Avg Operating Profit Margin
|
-415.88 % | -745.72 % | -95.87 % |
|
5 yr average Debt to Equity
|
3.19 | -0.73 | 0.68 |
|
5yr CAGR Net Profit
|
-27.26 % | n/a | -1.66 % |
|
5yr Average Return on Assets
|
-13.75 % | -33.34 % | -15.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.89 % | 16.85 % | 0.0 |
|
Share Pledged by Promoters
|
16.04 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -17.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
MPS Pharmaa
|
Hemo Organic
|
Zyden Gentec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|